Literature DB >> 19366739

Eliminating Chagas disease: challenges and a roadmap.

Richard Reithinger1, Rick L Tarleton, Julio A Urbina, Uriel Kitron, Ricardo E Gürtler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19366739      PMCID： PMC3085889          DOI： 10.1136/bmj.b1283

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  19 in total

Review 1.  The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination.

Authors:  Peter Hotez; Eric Ottesen; Alan Fenwick; David Molyneux
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

2.  Chagas' disease in Mexico.

Authors:  Amir Attaran
Journal:  Lancet       Date:  2006-11-18       Impact factor: 79.321

3.  The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.

Authors:  Marianne Pirard; Naomi Iihoshi; Marleen Boelaert; Paulino Basanta; Freddy López; Patrick Van der Stuyft
Journal:  Transfusion       Date:  2005-04       Impact factor: 3.157

4.  Extinction of experimental Triatoma infestans populations following continuous exposure to dogs wearing deltamethrin-treated collars.

Authors:  Richard Reithinger; Leonardo Ceballos; Raúl Stariolo; Clive R Davies; Ricardo E Gürtler
Journal:  Am J Trop Med Hyg       Date:  2006-05       Impact factor: 2.345

5.  Prevention of the transmission of Chagas' disease with pyrethroid-impregnated materials.

Authors:  Axel Kroeger; Elci Villegas; José Ordoñez-González; Eulides Pabon; José Vicente Scorza
Journal:  Am J Trop Med Hyg       Date:  2003-03       Impact factor: 2.345

6.  Development and validation of a risk score for predicting death in Chagas' heart disease.

Authors:  Anis Rassi; Anis Rassi; William C Little; Sérgio S Xavier; Sérgio G Rassi; Alexandre G Rassi; Gustavo G Rassi; Alejandro Hasslocher-Moreno; Andrea S Sousa; Maurício I Scanavacca
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

7.  Blood donor screening for chagas disease--United States, 2006-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-02-23       Impact factor: 17.586

Review 8.  Clinical and epidemiological aspects of Chagas disease.

Authors:  A Prata
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

Review 9.  The impact of Chagas disease control in Latin America: a review.

Authors:  J C P Dias; A C Silveira; C J Schofield
Journal:  Mem Inst Oswaldo Cruz       Date:  2002-07       Impact factor: 2.743

10.  Chagas disease in a domestic transmission cycle, southern Texas, USA.

Authors:  Charles B Beard; Greg Pye; Frank J Steurer; Ray Rodriguez; Richard Campman; A Townsend Peterson; Janine Ramsey; Robert A Wirtz; Laura E Robinson
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883
View more
  17 in total

1.  Rapid detection of Trypanosoma cruzi in human serum by use of an immunochromatographic dipstick test.

Authors:  Richard Reithinger; Mario J Grijalva; Rosa F Chiriboga; Belkisyolé Alarcón de Noya; Jaime R Torres; Norma Pavia-Ruz; Pablo Manrique-Saide; Marta V Cardinal; Ricardo E Gürtler
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

2.  Sustainability of vector control strategies in the Gran Chaco Region: current challenges and possible approaches.

Authors:  Ricardo E Gürtler
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

3.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

4.  Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.

Authors:  Claudia R De Marchi; Javier M Di Noia; Alberto C C Frasch; Vicente Amato Neto; Igor C Almeida; Carlos A Buscaglia
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

5.  Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi.

Authors:  Virginia Balouz; María de Los Milagros Cámara; Gaspar E Cánepa; Santiago J Carmona; Romina Volcovich; Nicolás Gonzalez; Jaime Altcheh; Fernán Agüero; Carlos A Buscaglia
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

6.  Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.

Authors:  Christopher A Seid; Kathryn M Jones; Jeroen Pollet; Brian Keegan; Elissa Hudspeth; Molly Hammond; Junfei Wei; C Patrick McAtee; Leroy Versteeg; Amanda Gutierrez; Zhuyun Liu; Bin Zhan; Jonathan L Respress; Ulrich Strych; Maria Elena Bottazzi; Peter J Hotez
Journal:  Hum Vaccin Immunother       Date:  2016-10-13       Impact factor: 3.452

7.  Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge.

Authors:  Matthew H Collins; Julie M Craft; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

8.  In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.

Authors:  Adriana M C Canavaci; Juan M Bustamante; Angel M Padilla; Cecilia M Perez Brandan; Laura J Simpson; Dan Xu; Courtney L Boehlke; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

9.  Toward Improving Early Diagnosis of Congenital Chagas Disease in an Endemic Setting.

Authors:  Louisa A Messenger; Robert H Gilman; Manuela Verastegui; Gerson Galdos-Cardenas; Gerardo Sanchez; Edward Valencia; Leny Sanchez; Edith Malaga; Victoria R Rendell; Malasa Jois; Vishal Shah; Nicole Santos; Maria Del Carmen Abastoflor; Carlos LaFuente; Rony Colanzi; Ricardo Bozo; Caryn Bern
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

10.  Is Chagas disease really the "new HIV/AIDS of the Americas"?

Authors:  Rick L Tarleton; James W Curran
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.